Physician profile
Thomas A Michelsen
NPI 1275591026
$2,269.67
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $899 · 2021: $650 · 2022: $42.41.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $384.36 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $213.85 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $210.70 | 2019-2021 | |
| Glaxosmithkline, LLC. | $197.15 | 2019-2022 | |
| Pfizer INC. | $184.40 | 2019-2021 | |
| Abbvie INC. | $129.09 | 2019-2021 | |
| Astellas Pharma US INC | $115.48 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.08 | 2020-2021 | |
| Lilly USA, LLC | $90.68 | 2019-2021 | |
| Amarin Pharma, INC. | $86.55 | 2020 | |
| Merck Sharp & Dohme LLC | $81.96 | 2020-2021 | |
| Allergan, INC. | $60.71 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $52.41 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.05 | 2019-2021 | |
| Medtronic Vascular, INC. | $43.29 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $36.38 | 2020-2022 | |
| Hologic Sales and Service, LLC | $30.57 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.48 | 2019 | |
| Daiichi Sankyo INC. | $30.02 | 2019-2020 | |
| Amgen INC. | $17.89 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.65 | 2021 | |
| Ethicon US, LLC | $13.98 | 2020 | |
| Dermira, INC. | $13.87 | 2020 | |
| Mannkind Corporation | $13.21 | 2020 | |
| Abbott Laboratories | $13.08 | 2019 | |
| Bardy Diagnostics, INC. | $12.00 | 2022 | |
| Exeltis, USA INC. | $11.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.21 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.08 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Michelsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.